Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury - Wikidata - wikimedia - TriplyDB

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

http://www.wikidata.org/entity/Q28085329

about

Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers Drug-disease interactions: narrative review of aspirin in gastric ulcer.Different Pathophysiology of Gastritis in East and West? A Western Perspective.

P2860

Q37192996-166919DC-BB68-492C-AEBC-24C4A11CB2B3 Q38870495-42D4C264-B7F2-4E14-AD7F-46AD769B0ED4 Q55318043-DC925EF4-2C39-4140-9ACF-AF3FD6AE2DF4

P2860

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

http://www.wikidata.org/entity/Q28085329

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@ast

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@en

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@nl

type

label

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@ast

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@en

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@nl

prefLabel

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@ast

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@en

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@nl

P1433

Q28085329-C4919F3E-F333-4604-B9D0-C6DC445A3BC5

P1476

Q28085329-D7B163D5-EE9B-49D3-88D9-F24863E97DA6

P2093

Q28085329-875020BF-CB5A-4A38-8A68-A9697C764CE8

P2860

Q28085329-0405DFD1-7759-4F05-B822-9CF94890434C

Q28085329-041C02A5-7C2E-439E-8742-87A57D9C8802

Q28085329-074FCCD2-3469-4D23-B67A-D1F6F5EDAEAF

Q28085329-0799B559-D3AF-4B7E-AB36-AD4902E0653E

Q28085329-0EF4D30D-0480-4D4D-B229-853B2C6B848A

Q28085329-15829D7B-DEE2-479A-9ED6-64D18AA4CDB4

Q28085329-17A1CF32-E46E-4B32-9B2E-4050ED1F9375

Q28085329-18D4594D-1A56-4A3B-9022-8AF0F219ECFC

Q28085329-1AA19D5D-0CC0-4590-B498-3FF9A2D6B14E

Q28085329-2127A8AF-EDBA-4770-ACA2-CB8488CE29E9

P304

Q28085329-D23FEDD8-01C6-4C1E-A20A-EDC7FFD2DE80

P31

Q28085329-6D6694F5-FF73-48F9-8715-29F6AB0911C3

P3181

Q28085329-9047F955-A295-4FC4-B46F-9D8DFD11DBB3

P356

Q28085329-0C7AF81D-9C81-403A-B1BA-502AA012F915

P407

Q28085329-EC6AE719-5DB5-43CE-AA98-F240344E3C8F

P433

Q28085329-65657908-A4DD-4C78-93CD-6B267948D730

P478

Q28085329-74265C9F-70E1-4D0A-B69B-9A7BCC1F86B7

P577

Q28085329-E8C5A53C-09AB-4DF1-9683-71E94A12BE52

P5875

Q28085329-769BB009-9844-465A-A3CB-2781DF1552C2

P698

Q28085329-5D4517BC-5848-4F86-B663-19439CB5C276

P921

Q28085329-8194608F-4314-4311-9471-7A60B8D8C32D

P932

Q28085329-979C0D7D-7D24-42C2-BA27-F55A76AB3F99

P3181

P356

WJG.V21.I25.7709

P1433

World Journal of Gastroenterology

P1476

Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury

@en

P2093

Katsunori Iijima

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

Helicobacter pylori infection in Japan

Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin

Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils

Endoscopy in asymptomatic minidose aspirin consumers

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

P304

7709-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4197240

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V21.I25.7709

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280060437

http://www.w3.org/2001/XMLSchema#string

P698

26167071

http://www.w3.org/2001/XMLSchema#string

P921

P932

4491958

http://www.w3.org/2001/XMLSchema#string